Search

Search Constraints

You searched for: Author/Creator Porta, C

Search Results

1. 64PPost-progression evaluation of patients treated with nivolumab for advanced non-small cell lung cancer: A prospective cohort analysis. (17th December 2018)

2. 874PTreatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis. (23rd October 2018)

3. 875PCharacterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with previously untreated advanced renal cell carcinoma (arcc): Checkmate 214. (23rd October 2018)

4. 891PCorrelation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study. (23rd October 2018)